Global G-Protein Coupled Receptor (GPCR) Targeting Market Insights, Forecast to 2025

G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein.

The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016.

In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%.

North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%.

Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry.

The global G-Protein Coupled Receptor (GPCR) Targeting market is valued at 79 million US$ in 2018 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 2.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the G-Protein Coupled Receptor (GPCR) Targeting market based on company, product type, end user and key regions.

This report studies the global market size of G-Protein Coupled Receptor (GPCR) Targeting in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of G-Protein Coupled Receptor (GPCR) Targeting in these regions.
This research report categorizes the global G-Protein Coupled Receptor (GPCR) Targeting market by top players/brands, region, type and end user. This report also studies the global G-Protein Coupled Receptor (GPCR) Targeting market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher Scientific
PerkinElmer
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Cisbio
Discoverx
Enzo Life Sciences

Market size by Product
GPCR Consumables
GPCR Equipment
Market size by End User
Oncology
Cardiovascular System
Central Nervous System
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global G-Protein Coupled Receptor (GPCR) Targeting market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of G-Protein Coupled Receptor (GPCR) Targeting market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global G-Protein Coupled Receptor (GPCR) Targeting companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of G-Protein Coupled Receptor (GPCR) Targeting submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of G-Protein Coupled Receptor (GPCR) Targeting are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of G-Protein Coupled Receptor (GPCR) Targeting market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions